Aino-Maija Leppä
@amleppa.bsky.social
110 followers 60 following 5 posts
Current | Postdoc at Francis Crick Institute with Charles Swanton exploring lung cancer evolution. Before | PhD at DKFZ with Andreas Trumpp charting AML heterogeneity.
Posts Media Videos Starter Packs
Reposted by Aino-Maija Leppä
verat-h.bsky.social
Thrilled to share that our work from Trumpp Lab @hi-stem @dkfz.bsky.social is out in Nature.
We provide the first single-cell data on neurons infiltrating pancreatic tumors, offering new insights into cancer therapy. #cancerneuroscience @cn-hd.bsky.social
www.nature.com/articles/s41...
Reposted by Aino-Maija Leppä
const-ae.bsky.social
After 4y in the making, I am super excited that my main PhD project is published 🎉🥳🎉🎉🥳

www.nature.com/articles/s41...

LEMUR is a tool to analyze multi-condition single-cell data and model differential expression as a continuous function of the cell-state space.

Some highlights⬇️
Overview of the LEMUR steps: (1) subspace alignment, (2) differential expression, (3) DE neighborhoods, (4) pseudobulking.
amleppa.bsky.social
I'm very thankful to everyone involved in the study! The project would not have been possible without my co-firsts Karen Grimes and Hyobin Jeong and co-lasts Andreas Trumpp, Jan Korbel and Ashley Sanders 🎉 🎊 5/5
amleppa.bsky.social
In another patient with paired pre- and post-treatment samples, two distinct subclones persisted post venetoclax-based treatment. Both had subclone-specific mechanisms to further resistance: a shift toward MEP-like cells and NF1 loss. Go and read more about the other cases! 📜 4/5
amleppa.bsky.social
For example, in one patient the sublclone driving relapse had a seismic amplification, upregulated DNA damage response and it also engrafted in mice. We could even see cell-to-cell differences in the copy-number states of the seismic amplification! 🌋 3/5
amleppa.bsky.social
We integrated single-cell resolution structural variants, nucleosome occupancy, gene expression and surface proteins to study subclonal growth patterns in complex karyotype AML patient samples 🧬 2/5